fibrinogen has been researched along with Smoking Cessation in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 16 (64.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Döring, A; Holz, T; Koenig, W; Meisinger, C; Schneider, A; Thorand, B | 1 |
| Alonso-Villaverde Grote, C; Bleda Fernández, D; Fernández Pérez, C; Muñoz Lloret, A; Peña Sendra, E; Pérez Santos, JM; Rodríguez Cristóbal, JJ; Travé Mercadé, P | 1 |
| De Faire, U; Falk, G; Hallqvist, J; Leander, K; Wiman, B | 1 |
| Chambless, LE; Duncan, BB; Folsom, AR; Heiss, G; Schmidt, MI | 1 |
| Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L | 1 |
| Cort, N; Haustein, H; Haustein, KO; Krause, J; Rasmussen, T | 1 |
| Bingham, S; Day, NE; Khaw, KT; Luben, RN; Sinha, S; Wareham, NJ; Welch, A | 1 |
| Lennon, L; Lowe, GD; Rumley, A; Shaper, AG; Wannamethee, SG; Whincup, PH | 1 |
| Bakhru, A; Erlinger, TP | 1 |
| Arocha-Piñango, CL; Campos, G; Carvajal, Z; Coll-Sangrona, E; Diez-Ewald, MP; Espinosa, R; Gill, A; Lundberg, U; Mijares, ME; Nagy, E; Rodríguez-Larralde, A; Rodríguez-Roa, E; Ryder, E; Torres, E | 1 |
| Ameratunga, R; Baldi, JC; French, JK; Hammett, CJ; Prapavessis, H; Schoenbeck, U; Stewart, RA; Varo, N; White, HD | 2 |
| Bliss, R; Carmella, SG; Gross, M; Hatsukami, DK; Hecht, SS; Joseph, AM; Lando, H; Le, CT; Murphy, SE | 1 |
| Benowitz, NL; Fitzgerald, GA; Wilson, M; Zhang, Q | 1 |
| Fagerström, KO; Lundgren, H; Nilsson, P; Nilsson-Ehle, P; Söderström, M | 1 |
| Bignell, A; Blann, A; McCollum, C | 1 |
| Sussekov, AV | 1 |
| Blöndal, T; Franzon, M; Gudmundsson, TV; Lúdvíksdóttir, D; Säwe, U | 1 |
| Anderson, SE; Broom, I; Garlick, PJ; Hunter, KA; McNurlan, MA | 1 |
| Lowe, GD | 1 |
| Eliasson, B; Hjalmarson, A; Kruse, E; Landfeldt, B | 1 |
| He, D; Høstmark, AT; Medbø, JI | 1 |
| Gladdish, S; Rajkumar, C | 1 |
| Burr, ML; Fehily, AM; Holliday, RM; Whitehead, PJ | 1 |
| Alexander, HM; Dobson, AJ; Heller, RF; Lloyd, DM | 1 |
1 review(s) available for fibrinogen and Smoking Cessation
| Article | Year |
|---|---|
Prevention of cardiac disease in the elderly.
Topics: Aged; Diabetes Complications; Exercise; Fibrinogen; Heart Diseases; Homocysteine; Humans; Hypertension; Lipids; Obesity; Risk Factors; Smoking Cessation; United Kingdom; Vitamin E | 2001 |
9 trial(s) available for fibrinogen and Smoking Cessation
| Article | Year |
|---|---|
Randomised clinical trial of an intensive intervention in the primary care setting of patients with high plasma fibrinogen in the primary prevention of cardiovascular disease.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diet; Exercise; Female; Fibrinogen; Humans; Hypertension; Life Style; Male; Middle Aged; Obesity; Primary Health Care; Primary Prevention; Risk Factors; Smoking; Smoking Cessation | 2012 |
Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT).
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Viscosity; Carbon Monoxide; Cotinine; Erythrocyte Deformability; Fibrinogen; Gingiva; Humans; Leukocytes; Male; Middle Aged; Nicotine; Smoking Cessation; Thiocyanates | 2004 |
Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; CD40 Ligand; Exercise; Female; Fibrinogen; Health Education; Health Status; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocyte Count; Physical Fitness; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Statistics, Nonparametric; Time Factors | 2006 |
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention | 2008 |
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Adult; Aged; beta-Thromboglobulin; Blood Coagulation; Cell Adhesion Molecules; Coronary Disease; Eicosanoids; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoproteins; Risk Factors; Smoking; Smoking Cessation; Thromboxane A2; Thromboxane B2 | 1993 |
Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration.
Topics: Adult; Blood Glucose; C-Peptide; Cardiovascular Diseases; Feasibility Studies; Female; Fibrinogen; Humans; Insulin; Lipids; Male; Middle Aged; Psychotherapy, Group; Risk Factors; Smoking; Smoking Cessation; Weight Gain | 1996 |
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.
Topics: Administration, Inhalation; Administration, Intranasal; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Erythrocyte Indices; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Platelet Count; Prospective Studies; Risk Factors; Smoking Cessation; Thrombosis | 1999 |
Effect of acupuncture on smoking cessation or reduction: an 8-month and 5-year follow-up study.
Topics: Acupuncture; Adult; Cotinine; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Norway; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Surveys and Questionnaires; Taste; Thiobarbituric Acid Reactive Substances; Thiocyanates; Time | 2001 |
Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART).
Topics: Blood Viscosity; Dietary Fats; Dietary Fiber; Fibrinogen; Fish Oils; Follow-Up Studies; Hemoglobinometry; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Recurrence; Smoking; Smoking Cessation; Survival Rate | 1992 |
15 other study(ies) available for fibrinogen and Smoking Cessation
| Article | Year |
|---|---|
Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA/KORA S3/F3 study.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Obesity; Odds Ratio; Smoking; Smoking Cessation; Weight Gain | 2010 |
The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
Topics: Age Factors; Aged; Alleles; Chi-Square Distribution; Exercise; Female; Fibrinogen; Genotype; Humans; Hypercholesterolemia; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires | 2002 |
Inflammation markers predict increased weight gain in smoking quitters.
Topics: Biomarkers; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Odds Ratio; Smoking; Smoking Cessation; Weight Gain | 2003 |
Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Carboxyhemoglobin; Ceruloplasmin; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Orosomucoid; Prospective Studies; Risk; Smoking; Smoking Cessation; Stroke; Surveys and Questionnaires; Sweden | 2004 |
Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population.
Topics: Age Distribution; Aged; Body Mass Index; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Europe; Female; Fibrinogen; Health Surveys; Humans; Incidence; Life Style; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Sex Distribution; Smoking; Smoking Cessation; Survival Analysis | 2005 |
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Smoking Cessation | 2005 |
Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Risk Factors; Risk Reduction Behavior; Serum Albumin; Smoking; Smoking Cessation; United States | 2005 |
[Relation of socioeconomic levels and life style to fibrinogen and von Willebrand factor in healthy Venezuelans and those with ischemic cardiopathy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Alcoholism; Female; Fibrinogen; Global Health; Humans; Life Style; Male; Middle Aged; Motor Activity; Myocardial Ischemia; Poverty; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Social Class; Temperance; Venezuela; von Willebrand Factor | 2005 |
Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; CD40 Ligand; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Leukocyte Count; Middle Aged; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Smoking; Smoking Cessation | 2007 |
von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.
Topics: Adult; Aged; Arteries; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Smoking Cessation; Vascular Diseases; von Willebrand Factor | 1998 |
Hyperlipidaemia and cardiovascular disease.
Topics: Coronary Disease; Exercise; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Risk Factors; Smoking Cessation | 1998 |
Effects of smoking and abstention from smoking on fibrinogen synthesis in humans.
Topics: Adult; Fibrinogen; Humans; Male; Middle Aged; Serum Albumin; Smoking; Smoking Cessation | 2001 |
Why do smokers have higher plasma fibrinogen levels than non-smokers?
Topics: Case-Control Studies; Coronary Disease; Cytokines; Dose-Response Relationship, Drug; Fibrinogen; Humans; Male; Smoking; Smoking Cessation | 2001 |
Effect of smoking reduction and cessation on cardiovascular risk factors.
Topics: Adult; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Lipoproteins, HDL; Male; Nicotine; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Triglycerides | 2001 |
How soon after quitting smoking does risk of heart attack decline?
Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Time Factors | 1991 |